Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Yeang HXA"'
Autor:
D'Souza C; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne. criselle.dsouza@petermac.org., Keam SP; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Australia; Tumour Suppression and Cancer Sex Disparity Laboratory, Peter MacCallum Cancer Centre, Melbourne., Yeang HXA; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne., Neeson M; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne., Richardson K; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne., Hsu AK; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne., Canfield R; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne., Bezman N; Oncology Discovery Research, Bristol-Myers Squibb, Redwood City, CA, USA. Current: Arsenal Bio, San Francisco, CA 94080., Robbins M; Translational Medicine, Bristol-Myers Squibb, Cambridge, MA, USA, (current: io904 LLC)., Quach H; Department of Hematology, St Vincent's Hospital, Melbourne, Australia; Faculty of Medicine, University of Melbourne., Ritchie DS; Tumour Suppression and Cancer Sex Disparity Laboratory, Peter MacCallum Cancer Centre, Melbourne, Australia; Faculty of Medicine, University of Melbourne, Australia; Clinical Hematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne., Harrison SJ; Tumour Suppression and Cancer Sex Disparity Laboratory, Peter MacCallum Cancer Centre, Melbourne, Australia; Clinical Hematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne., Trapani JA; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne., Prince HM; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Australia; Clinical Hematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne., Beavis PA; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne., Darcy PK; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne., Neeson PJ; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne. paul.neeson@petermac.org.
Publikováno v:
Haematologica [Haematologica] 2021 Sep 01; Vol. 106 (9), pp. 2522-2526. Date of Electronic Publication: 2021 Sep 01.
Autor:
Tantalo D; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Nguyen T; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Yeang HXA; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Zhu J; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Macdonald S; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Wang M; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., de Silva H; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., D'Souza C; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Pizzolla A; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Neeson PJ; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. paul.neeson@petermac.org.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia. paul.neeson@petermac.org.
Publikováno v:
Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2021; Vol. 2265, pp. 543-555.
Autor:
Nguyen T; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Kocovski N; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Macdonald S; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Yeang HXA; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, Parkville, VIC, Australia., Wang M; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, Parkville, VIC, Australia., Neeson PJ; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. paul.neeson@petermac.org.; Sir Peter MacCallum Department of Oncology, Parkville, VIC, Australia. paul.neeson@petermac.org.
Publikováno v:
Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2021; Vol. 2265, pp. 557-572.
Autor:
Wang M; Upper Gastrointestinal Translational Research Laboratory Peter MacCallum Cancer Centre Melbourne VIC Australia.; Sir Peter MacCallum Department of Oncology The University of Melbourne Melbourne VIC Australia.; Department of Medicine, Royal Melbourne Hospital The University of Melbourne Melbourne VIC Australia.; Cancer Immunology Research Peter MacCallum Cancer Centre Melbourne VIC Australia., Huang YK; Upper Gastrointestinal Translational Research Laboratory Peter MacCallum Cancer Centre Melbourne VIC Australia.; Sir Peter MacCallum Department of Oncology The University of Melbourne Melbourne VIC Australia.; Department of Medicine, Royal Melbourne Hospital The University of Melbourne Melbourne VIC Australia., Kong JC; Sir Peter MacCallum Department of Oncology The University of Melbourne Melbourne VIC Australia.; Department of Medicine, Royal Melbourne Hospital The University of Melbourne Melbourne VIC Australia., Sun Y; Sir Peter MacCallum Department of Oncology The University of Melbourne Melbourne VIC Australia., Tantalo DG; Cancer Immunology Research Peter MacCallum Cancer Centre Melbourne VIC Australia., Yeang HXA; Cancer Immunology Research Peter MacCallum Cancer Centre Melbourne VIC Australia., Ying L; Centre for Innate Immunity and Infectious Diseases Hudson Institute of Medical Research Clayton VIC Australia., Yan F; Australian Centre for Blood Diseases Central Clinical School Monash University Melbourne VIC Australia., Xu D; Faculty of Medical Laboratory Science Ruijin Hospital School of Medicine Shanghai Jiao Tong University Shanghai China., Halse H; Cancer Immunology Research Peter MacCallum Cancer Centre Melbourne VIC Australia., Di Costanzo N; Upper Gastrointestinal Translational Research Laboratory Peter MacCallum Cancer Centre Melbourne VIC Australia., Gordon IR; Statistical Consulting Centre School of Mathematics and Statistics The University of Melbourne Melbourne VIC Australia., Mitchell C; Department of Pathology Peter MacCallum Cancer Centre Melbourne VIC Australia., Mackay LK; Department of Microbiology and Immunology Peter Doherty Institute for Infection and Immunity University of Melbourne Melbourne VIC Australia., Busuttil RA; Upper Gastrointestinal Translational Research Laboratory Peter MacCallum Cancer Centre Melbourne VIC Australia.; Sir Peter MacCallum Department of Oncology The University of Melbourne Melbourne VIC Australia.; Department of Medicine, Royal Melbourne Hospital The University of Melbourne Melbourne VIC Australia., Neeson PJ; Sir Peter MacCallum Department of Oncology The University of Melbourne Melbourne VIC Australia.; Cancer Immunology Research Peter MacCallum Cancer Centre Melbourne VIC Australia.; Department of Pathology The University of Melbourne Melbourne VIC Australia., Boussioutas A; Upper Gastrointestinal Translational Research Laboratory Peter MacCallum Cancer Centre Melbourne VIC Australia.; Sir Peter MacCallum Department of Oncology The University of Melbourne Melbourne VIC Australia.; Department of Medicine, Royal Melbourne Hospital The University of Melbourne Melbourne VIC Australia.
Publikováno v:
Clinical & translational immunology [Clin Transl Immunology] 2020 May 05; Vol. 9 (5), pp. e1127. Date of Electronic Publication: 2020 May 05 (Print Publication: 2020).
Autor:
Thaventhiran T; 1 Medical Research Council Centre for Drug Safety Science and Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom., Wong W; 1 Medical Research Council Centre for Drug Safety Science and Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom., Alghanem AF; 1 Medical Research Council Centre for Drug Safety Science and Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom., Alhumeed N; 1 Medical Research Council Centre for Drug Safety Science and Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom., Aljasir MA; 1 Medical Research Council Centre for Drug Safety Science and Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom., Ramsey S; 2 Inflammation and Remodeling, Pfizer Research Unit, Cambridge, Massachusetts., Sethu S; 1 Medical Research Council Centre for Drug Safety Science and Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom., Yeang HXA; 1 Medical Research Council Centre for Drug Safety Science and Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom., Chadwick AE; 1 Medical Research Council Centre for Drug Safety Science and Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom., Cross M; 1 Medical Research Council Centre for Drug Safety Science and Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom., Webb SD; 1 Medical Research Council Centre for Drug Safety Science and Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom., Djouhri L; 3 Department of Physiology, College of Medicine, King Saud University, Riyadh, Saudi Arabia., Ball C; 4 National Institute for Biological Standards and Control, Hertfordshire, United Kingdom., Stebbings R; 4 National Institute for Biological Standards and Control, Hertfordshire, United Kingdom., Sathish JG; 1 Medical Research Council Centre for Drug Safety Science and Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom.
Publikováno v:
Monoclonal antibodies in immunodiagnosis and immunotherapy [Monoclon Antib Immunodiagn Immunother] 2019 Apr; Vol. 38 (2), pp. 60-69.
Autor:
Yeang HXA; Department of Pharmacology, Medical Research Council Centre for Drug Safety Science, University of Liverpool, Sherrington Buildings, Ashton Street, Liverpool L69 3GE, United Kingdom., Hamdam JM; Department of Pharmacology, Medical Research Council Centre for Drug Safety Science, University of Liverpool, Sherrington Buildings, Ashton Street, Liverpool L69 3GE, United Kingdom., Al-Huseini LMA; Department of Pharmacology, Medical Research Council Centre for Drug Safety Science, University of Liverpool, Sherrington Buildings, Ashton Street, Liverpool L69 3GE, United Kingdom., Sethu S; Department of Pharmacology, Medical Research Council Centre for Drug Safety Science, University of Liverpool, Sherrington Buildings, Ashton Street, Liverpool L69 3GE, United Kingdom., Djouhri L; Department of Pharmacology, Medical Research Council Centre for Drug Safety Science, University of Liverpool, Sherrington Buildings, Ashton Street, Liverpool L69 3GE, United Kingdom., Walsh J; Department of Pharmacology, Medical Research Council Centre for Drug Safety Science, University of Liverpool, Sherrington Buildings, Ashton Street, Liverpool L69 3GE, United Kingdom., Kitteringham N; Department of Pharmacology, Medical Research Council Centre for Drug Safety Science, University of Liverpool, Sherrington Buildings, Ashton Street, Liverpool L69 3GE, United Kingdom., Park BK; Department of Pharmacology, Medical Research Council Centre for Drug Safety Science, University of Liverpool, Sherrington Buildings, Ashton Street, Liverpool L69 3GE, United Kingdom., Goldring CE; Department of Pharmacology, Medical Research Council Centre for Drug Safety Science, University of Liverpool, Sherrington Buildings, Ashton Street, Liverpool L69 3GE, United Kingdom. Electronic address: chrissy@liv.ac.uk., Sathish JG; Department of Pharmacology, Medical Research Council Centre for Drug Safety Science, University of Liverpool, Sherrington Buildings, Ashton Street, Liverpool L69 3GE, United Kingdom. Electronic address: Jean.Sathish@liv.ac.uk.
Publikováno v:
The Journal of biological chemistry [J Biol Chem] 2012 Mar 23; Vol. 287 (13), pp. 10556-10564. Date of Electronic Publication: 2012 Feb 06.